GA in 2025: Dosing Regimens, Drug Selection, and Ideal Candidates
Update: 2025-07-07
Description
How tightly should you stick to a GA therapy’s label? Which complement inhibitor do you pick and why? And which candidates are best suited for treatment? In part 1 of this 2-part series, moderator Judy Kim, MD, and panelists Sunir Garg, MD; Deepak Sambhara, MD, and Rishi Singh, MD, explore these questions in a brief (but enlightening) discussion.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
